Viridian Therapeutics Inc (NAS:VRDN)
$ 11.95 0.01 (0.08%) Market Cap: 762.68 Mil Enterprise Value: 369.62 Mil PE Ratio: 0 PB Ratio: 1.99 GF Score: 44/100

Q4 2020 Viridian Therapeutics Inc Earnings Call Transcript

Mar 25, 2021 / 08:30PM GMT
Release Date Price: $17.27 (-1.26%)
Operator

Welcome to the Viridian Therapeutics Fourth Quarter and Full Year 2020 Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Dan Ferry of LifeSci Advisors. Please go ahead, sir.

Daniel Ferry
LifeSci Advisors, LLC - MD & Relationship Manager

Thank you, operator. Good afternoon, everyone, and welcome to our fourth quarter and full year 2020 conference call. Today, after the market closed, we issued a press release providing our fourth quarter and full year-end 2020 financial results and business updates. A replay of today's call will be available on the Investors section of our website approximately 1 hour after its completion. After our prepared remarks, we will open the call for Q&A.

Before we begin, I would like to remind everyone that this conference call and webcast will contain forward-looking statements about the company. These statements are subject to risks and uncertainties that could cause actual results to differ. Please note that these forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot